Related Experiment Video
Updated: Apr 12, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
The gut microbiota and inflammatory bowel disease
Yoshiyuki Goto1, Yosuke Kurashima, Hiroshi Kiyono
1aInternational Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo bMedical Mycology Research Center, Chiba University, Chiba cDivision of Mucosal Immunology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Inflammatory bowel diseases (IBDs) arise from complex interactions between the gut microbiota and the immune system. Restoring gut homeostasis through beneficial bacteria or fecal transplants can help manage IBDs.
Area of Science:
- Gastroenterology and Immunology
- Microbiome Research
Background:
- Inflammatory bowel diseases (IBDs) result from intricate interactions between host genetics, environmental factors, gut microbiota, and the intestinal immune system.
- The gut microbiota and mucosal immune system play critical roles in the development and regulation of IBDs.
Purpose of the Study:
- This review focuses on the interplay between the gut microbiota and the mucosal immune system in the context of IBD development and management.
- To elucidate the features of the gut microbiota and mucosal immune system crucial for IBD pathogenesis and control.
Main Methods:
- Review of current scientific literature on the gut microbiome and immune system in IBD.
- Analysis of the roles of innate and acquired immune cells in maintaining gut homeostasis.
- Examination of factors contributing to dysbiosis and epithelial barrier dysfunction.
Main Results:
- Gut innate immune cells (dendritic cells, innate lymphoid cells, mast cells) are key in educating acquired immune cells and epithelial cells for symbiosis with commensal bacteria.
- Perturbations in commensal microorganism populations, genetic variations affecting immune responses, and compromised epithelial barriers can lead to IBD.
- Interventions like probiotics and fecal microbiota transplantation can restore gut homeostasis and alleviate IBD symptoms.
Conclusions:
- A symbiotic relationship between the gut immune system and commensal bacteria is essential for intestinal health.
- Dysbiosis, epithelial barrier defects, and immune system dysregulation disrupt this mutualism, causing IBD.
- Advances in understanding the molecular and cellular mechanisms of host-microbiota interactions offer promising therapeutic strategies for IBD treatment.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Functions of the Gut Microbiota
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Gut-Brain Axis

